Jean Combalbert is a PharmD and PhD receive from the University of Pharmacy, Marseille France. Jean has an impressive track record with over 25 years’ of experience building research and development-stage biotech companies and achieving high-value exits. Jean is the founder and non-executive director at Epics Therapeutics SA, having previously served as its founding CEO from 2017. He is also currently non-executive Chairman of Kynos Therapeutics Ltd, Scotland and Dendrogenix SA, Belgium. Jean was Chairman of the Board at Syndesi Therapeutics SA, Belgium from 2018 until its sale (USD 1B) to AbbVie in 2022. Previously, he was CEO of Ogeda SA from 2006 until its sale (EUR 800M) to Astellas Pharma Inc. in 2017. Earlier in his career, Dr Combalbert held senior positions with SANOFI Research and Galderma in France and the United States.